ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,514Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 421

$936K Total Retail Price of All Prescriptions

Rank: 5 out of 421

1,106 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 12,995 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
CARVEDILOL 882 680 1 1
PRAVASTATIN SODIUM 833 763 2 12
AMLODIPINE BESYLATE 644 563 3 4
FUROSEMIDE 543 452 4 5
DIGOXIN 505 405 5 14
CRESTOR 415 309 6 15
ATORVASTATIN CALCIUM 411 367 7 9
SIMVASTATIN 409 306 8 6
CLOPIDOGREL 391 343 9 10
ISOSORBIDE MONONITRATE ER 382 339 10 11
WARFARIN SODIUM 379 334 11 7
LOSARTAN POTASSIUM 374 305 12 16
BYSTOLIC 315 259 13 29
PLAVIX 307 274 14 13
LISINOPRIL 285 231 15 2
METOPROLOL TARTRATE 280 236 16 3
POTASSIUM CHLORIDE 275 202 17 19
DIOVAN 271 248 18 23
METOPROLOL SUCCINATE 270 241 19 8
LOSARTAN-HYDROCHLOROTHIAZIDE 255 193 20 36
HYDRALAZINE HCL 243 228 21 21
NIASPAN 239 200 22 35
KLOR-CON M20 238 225 23 27
DILTIAZEM 24HR ER 231 172 24 39
RANEXA 227 202 25 31
SPIRONOLACTONE 225 157 26 20
DIOVAN HCT 219 204 27 52
DILTIAZEM HCL 198 171 28 85
FENOFIBRATE 191 149 29 40
DILTIAZEM ER 188 170 30 62
PINDOLOL 188 184 10 30 100
HYDROCHLOROTHIAZIDE 186 138 32 18
BISOPROLOL FUMARATE 184 135 33 79
LABETALOL HCL 183 161 34 75
ACEBUTOLOL HCL 155 145 35 108
PRADAXA 151 151 36 25
AMLODIPINE BESYLATE-BENAZEPRIL 139 112 37 66
ATENOLOL 131 97 38 17
EFFIENT 126 87 39 47
BENAZEPRIL HCL 123 104 40 48
ZETIA 108 88 41 26
DILTIAZEM 24HR CD 106 92 42 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 91 43 34
AMIODARONE HCL 91 72 44 22
SOTALOL 86 77 45 38
MULTAQ 83 83 46 65
XARELTO 77 66 47 78
LOVAZA 76 75 48 82
PANTOPRAZOLE SODIUM 74 59 49 41
DOXAZOSIN MESYLATE 74 74 49 61
RAMIPRIL 71 56 51 32
INDAPAMIDE 67 64 52 96
METOLAZONE 65 44 53 87
EXFORGE 64 53 54 114
NITROSTAT 64 57 54 24
FAMOTIDINE 56 44 56 64
CARTIA XT 55 45 57 129
BENICAR HCT 50 48 58 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.